A 58-year-old male patient presents with a five-year history of suprapubic pain, nocturia, dysuria, recurrent urinary tract ...

The FDA designates the TOBY Test as a breakthrough device, revolutionizing bladder cancer detection with a non-invasive, ...

Bladder cancer, often misunderstood, affects both men and women, not just the elderly. While smoking is a significant risk factor, genetics and chemic ...

Higher body fat, especially android fat, BMI, and waist size, is linked to stress urinary incontinence in midlife women, but ...

A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas ...

A variety of genetic predispositions, such as Lynch syndrome, is also implicated in bladder cancer. Even so, 30% of people with bladder cancer have no identifiable risk.

The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer.

Local News 18 Mass. highway plazas are being rebuilt. Here’s what to know The project would deliver the greatest changes the Massachusetts Turnpike plazas have seen since the highway was built ...

China’s home-grown AG600, the world’s largest amphibious aircraft, has been given the green light for mass production, marking a step forward in building an independent and globally ...

One man is dead after the car he was driving hit a tree in Chelmsford, Massachusetts, on Monday night, police said.

The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing an alternative treatment as opposed to traditional surgical procedures.

At 101 years old, North Andover resident Ethel Somers is living proof that age is just a number.